EBAMed develops innovative solutions for non-invasive and automated treatment of heart arrhythmias by using ion beams.
EBAMed has raised $1.7M in total funding. The most recent round was Series A. The last funding was announced in January 2025.
EBAMed's investors include CDP Venture Capital, Panakes Partners, Mayo Clinic, European Innovation Council, MassChallenge.
EBAMed is headquartered in Geneva, Switzerland.
EBAMed develops innovative solutions for non-invasive and automated treatment of heart arrhythmias by using ion beams.
EBAMed is at the Series A stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"EBAMed — Funding & Investors." VCBacked, January 21, 2025, https://www.vcbacked.co/company/ebamed. Accessed July 19, 2026.
VCBacked. (2025). EBAMed — Funding & Investors. Retrieved July 19, 2026, from https://www.vcbacked.co/company/ebamed
{{cite web |title=EBAMed — Funding & Investors |url=https://www.vcbacked.co/company/ebamed |website=VCBacked |access-date=July 19, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated